Risk factors for venous thromboembolism occurring during treatment of multiple myeloma with thalidomide or lenalidomide and its prevention

Yu　Yaping

PDF(912 KB)
PDF(912 KB)
Adverse Drug Reactions Journal ›› 2009, Vol. 11 ›› Issue (6) : 410-6.
安全用药

Risk factors for venous thromboembolism occurring during treatment of multiple myeloma with thalidomide or lenalidomide and its prevention

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2009, 11(6): 410-6

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(912 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉